SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma
E. Zucca
Bayer Bms Cellestia Incyte Astra Zeneca
Loxo Oncology
Novartis Pfizer Philogen Merck Msd
Prelude Therapeutics
· 0 citations
· 25 references